These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37288327)

  • 1. Usefulness of Serum Leucine-rich Alpha 2 Glycoprotein in Crohn's Disease: Is There Any Difference between Small Intestine and Colonic Lesions?
    Matsumoto S; Mashima H
    Crohns Colitis 360; 2023 Jul; 5(3):otad028. PubMed ID: 37288327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of Serum Leucine-Rich Alpha-2 Glycoprotein in Evaluating Endoscopic Disease Activity in Crohn's Disease.
    Kawamura T; Yamamura T; Nakamura M; Maeda K; Sawada T; Ishikawa E; Iida T; Mizutani Y; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M
    Inflamm Bowel Dis; 2023 Feb; 29(2):245-253. PubMed ID: 35436345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn's Disease.
    Asonuma K; Kobayashi T; Kikkawa N; Nakano M; Sagami S; Morikubo H; Miyatani Y; Hojo A; Fukuda T; Hibi T
    Inflamm Intest Dis; 2023; 8(1):13-22. PubMed ID: 37404381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of leucine-rich alpha-2-glycoprotein and assessment by small bowel capsule endoscopy are prognostic for Crohn's disease patients.
    Ito T; Dai K; Horiuchi M; Horii T; Furukawa S; Maemoto A
    JGH Open; 2023 Sep; 7(9):645-651. PubMed ID: 37744712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum leucine-rich alpha-2 glycoprotein as a predictive factor of endoscopic remission in Crohn's disease.
    Abe I; Shiga H; Chiba H; Miyazawa T; Oomori S; Shimoyama Y; Moroi R; Kuroha M; Kakuta Y; Kinouchi Y; Masamune A
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1741-1748. PubMed ID: 35641439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Leucine-Rich Alpha-2 Glycoprotein in Quiescent Crohn's Disease as a Potential Surrogate Marker for Small-Bowel Ulceration detected by Capsule Endoscopy.
    Omori T; Sasaki Y; Koroku M; Murasugi S; Yonezawa M; Nakamura S; Tokushige K
    J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of serum leucine-rich alpha-2 glycoprotein in predicting findings of Crohn's disease small bowel lesion in capsule endoscopy.
    Omori T; Koroku M; Murasugi S; Ito A; Yonezawa M; Nakamura S; Tokushige K
    Intest Res; 2024 May; ():. PubMed ID: 38712361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucine-Rich Alpha-2 Glycoprotein in Monitoring Disease Activity and Intestinal Stenosis in Inflammatory Bowel Disease.
    Yoshida T; Shimodaira Y; Fukuda S; Watanabe N; Koizumi S; Matsuhashi T; Onochi K; Iijima K
    Tohoku J Exp Med; 2022 Jul; 257(4):301-308. PubMed ID: 35598974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of the Optimal Cutoff Value and Delta Value of Leucine-Rich Alpha 2 Glycoprotein in Ulcerative Colitis.
    Matsumoto S; Mashima H
    Crohns Colitis 360; 2022 Oct; 4(4):otac039. PubMed ID: 36778513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Crohn's Disease Small-Bowel Mucosal Healing Using Capsule Endoscopy and Usefulness of Leucine-Rich α2-Glycoprotein.
    Hiraga H; Chinda D; Hasui K; Murai Y; Maeda T; Higuchi N; Ogasawara K; Kudo S; Sawada Y; Tatsuta T; Kikuchi H; Ebina M; Hiraga N; Mikami T; Sakuraba H; Fukuda S
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of Serum Leucine-Rich Alpha-2 Glycoprotein as a Surrogate Marker of Small Bowel Mucosal Injury in Crohn's Disease.
    Saiki T; Torisu T; Harada A; Kajiya Y; Taniguchi Y; Morisaki S; Umeno J; Suekane H; Kitazono T
    Inflamm Intest Dis; 2023 Oct; 8(2):69-76. PubMed ID: 37901342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Utility of Leucine-Rich Alpha-2-Glycoprotein as a Biomarker in Ulcerative Colitis: A Predictor of Endoscopic Remission Independent of Symptoms.
    Hayashi T; Kitamura K; Usami M; Miyazawa M; Nishitani M; Dejima A; Yamamoto M; Kawase S; Funaki M; Orita N; Nakagawa H; Morita K; Iida N; Seki A; Nio K; Kido H; Takayama H; Takeuchi Y; Yamada S; Takatori H; Shimada M; Saito H; Yamamoto D; Toyama T; Yamashita T
    Inflamm Intest Dis; 2023 Dec; 8(4):133-142. PubMed ID: 38115911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn's disease in clinical remission.
    Nasuno M; Shimazaki H; Nojima M; Hamada T; Sugiyama K; Miyakawa M; Tanaka H
    Medicine (Baltimore); 2023 Aug; 102(32):e34628. PubMed ID: 37565885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucine-rich alpha-2 glycoprotein is useful in predicting clinical relapse in patients with Crohn's disease during biological remission.
    Nakamura N; Honzawa Y; Ito Y; Sano Y; Yagi N; Kobayashi S; Aoi M; Tomiyama T; Tahara T; Fukata N; Fukui T; Naganuma M
    Intest Res; 2024 Aug; ():. PubMed ID: 39155217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease.
    Yasutomi E; Inokuchi T; Hiraoka S; Takei K; Igawa S; Yamamoto S; Ohmori M; Oka S; Yamasaki Y; Kinugasa H; Takahara M; Harada K; Furukawa M; Itoshima K; Okada K; Otsuka F; Tanaka T; Mitsuhashi T; Kato J; Okada H
    Sci Rep; 2021 May; 11(1):11086. PubMed ID: 34045529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.
    Shinzaki S; Matsuoka K; Tanaka H; Takeshima F; Kato S; Torisu T; Ohta Y; Watanabe K; Nakamura S; Yoshimura N; Kobayashi T; Shiotani A; Hirai F; Hiraoka S; Watanabe M; Matsuura M; Nishimoto S; Mizuno S; Iijima H; Takehara T; Naka T; Kanai T; Matsumoto T
    J Gastroenterol; 2021 Jun; 56(6):560-569. PubMed ID: 33942166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of plasma alternative to serum for measuring leucine-rich α2-glycoprotein as a biomarker of inflammatory bowel disease.
    Ichimiya T; Kazama T; Ishigami K; Yokoyama Y; Hayashi Y; Takahashi S; Itoi T; Nakase H
    PLoS One; 2023; 18(6):e0286415. PubMed ID: 37352151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of leucine-rich alpha-2 glycoprotein and fecal markers detect Crohn's disease activity confirmed by balloon-assisted enteroscopy.
    Kawamoto A; Takenaka K; Hibiya S; Kitazume Y; Shimizu H; Fujii T; Saito E; Ohtsuka K; Okamoto R
    Intest Res; 2024 Jan; 22(1):65-74. PubMed ID: 37939721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis.
    Shinzaki S; Matsuoka K; Iijima H; Mizuno S; Serada S; Fujimoto M; Arai N; Koyama N; Morii E; Watanabe M; Hibi T; Kanai T; Takehara T; Naka T
    J Crohns Colitis; 2017 Jan; 11(1):84-91. PubMed ID: 27466171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.